Market Overview

Benzinga's Top Pre-Market Losers

Related MNKD
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
MannKind: FDA Delays Afrezza Decision by Three Months (Fox Business)
Related SWHC
Is A Short Squeeze Ahead for Smith & Wesson (SWHC)? - Tale of the Tape
Smith & Wesson to Buy Back More Shares - Analyst Blog

MannKind (NASDAQ: MNKD) shares dropped 5.08% to $5.98 in pre-market trading after analysts at Bank of America downgraded the stock from “neutral” to “underperform.”

Smith & Wesson Holding (NASDAQ: SWHC) dipped 4.18% to $11 in the pre-market session after the company issued a downbeat Q2 forecast.

Immunomedics (NASDAQ: IMMU) dipped 3.33% to $6.10 in the pre-market session. Immunomedics's trailing-twelve-month ROE is -35.92%.

Carnival (NYSE: CCL) shares fell 0.47% to $35.77 in the pre-market trading. Carnival shares have dropped 3.00% over the past 52 weeks, while the S&P 500 index has gained 15.10% in the same period.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Most Popular

Related Articles (IMMU + CCL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free